Saturday, July 11, 2026

pharma · Acute Myeloid Leukemia · Narcolepsy · JAZZ

Jazz Pharmaceuticals Ireland

Jazz Pharmaceuticals Ireland is a pharma organization headquartered in Dublin, IE. It trades on NYSE under ticker JAZZ. Primary therapeutic focus areas include Acute Myeloid Leukemia, Narcolepsy, Epilepsy, Acute Lymphobl

Waterloo Exchange, Waterloo Road, Dublin, 4, IE HQ
2003 Founded
3,631 Employees
Public company Type
JAZZ · NYSE Ticker
Company details
Status
Public
HQ
Waterloo Exchange, Waterloo Road, Dublin, 4, IE
Founded
2003
Employees
3,631
Programs
208
Drugs
91
Patents
89
Clinical program

Sativex® (Treatment A)

Phase 1 · small molecule · Healthy Subjects

Sativex® (Treatment A) for Healthy Subjects is a Phase 1 program (small_molecule) at Jazz Pharmaceuticals Ireland Limited with 1 ClinicalTrials.gov record(s).

Internal code GWCP1427

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Jazz Pharmaceuticals Ireland Limited
Phase
Phase 1
Modality
small_molecule
Indication
Healthy Subjects
Status
completed
Trials
1

Clinical trials